SBCWW:NSD-SBC Medical Group Holdings Incorporated (USD)

COMMON STOCK | Consulting Services |

Last Closing

USD 0.28

Change

+0.03 (+10.02)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Consulting Services

Symbol Name Price(Change) Market Cap
VRSK Verisk Analytics Inc

+0.74 (+0.26%)

USD 39.01B
ICFI ICF International Inc

-2.26 (-1.87%)

USD 2.23B
HURN Huron Consulting Group Inc

-1.24 (-0.96%)

USD 2.21B
CRAI CRA International Inc

-1.10 (-0.59%)

USD 1.26B
FORR Forrester Research Inc

+0.01 (+0.06%)

USD 0.30B
RGP Resources Connection Inc

+0.04 (+0.47%)

USD 0.28B
AERT Aeries Technology Inc.

-0.07 (-8.91%)

USD 0.04B
VCIG VCI Global Limited Ordinary Sh..

-0.08 (-7.35%)

USD 0.03B
GRNQ GreenPro Capital Corp

N/A

USD 8.86M
SBC SBC Communications Inc.

+0.01 (+0.20%)

N/A

ETFs Containing SBCWW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Consulting Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.62% 100% F 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.62% 100% F 89% A-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector